Open AccessOperative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients
Author(s) -
Jürgen Kreutzer,
R Buslei,
H Wallaschofski,
Bernd Hofmann,
Christopher Nimsky,
Rudolf Fahlbusch,
Michael Buchfelder
Publication year - 2008
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-07-0248
Subject(s) - medicine , prolactinoma , transsphenoidal surgery , surgery , primary treatment , medical therapy , adenoma , spontaneous remission , pituitary adenoma , prolactin , pathology , alternative medicine , hormone
Medical therapy with dopamine agonists (DA) is the primary treatment of choice in most patients with prolactinomas. 'Classical' surgical indications are intolerance or lack of efficiency of DA therapy. Focusing on a possible shift of recent indications, we retrospectively analyzed our results of surgical treatment in prolactinomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom